We have previously shown that high cyclooxygenase‐2 (COX‐2) expression is associated with a poor prognosis of patients with NPC and inhibits chemotherapy‐induced senescence in NPC cells. The gene discussed is PTGS2; the disease is nasopharyngeal carcinoma.